Reported Tuberculosis in the United States, 2021

Return to Main Menu

Table 16. Tuberculosis Cases and Percentages Among U.S.-Born Persons1 by Drug Resistance and History of Previous TB Disease: United States, 1993–2021

See Surveillance Slide #48.

Tuberculosis cases and percentages by drug resistance and history of tuberculosis among U.S.–born persons.
Year Total cases2 Isoniazid (INH)-resistant3 Multidrug resistant (MDR)4 Previous TB No previous TB
Total cases INH-resistant MDR Total cases INH-resistant MDR
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
2021 1,574 92 (5.8) 11 (0.7) 40 0 (0.0) 0 (0.0) 1,514 90 (5.9) 11 (0.7)
2020 1,473 73 (5.0) 3 (0.2) 43 4 (9.3) 0 (0.0) 1,420 68 (4.8) 3 (0.2)
2019 1,898 125 (6.6) 13 (0.7) 58 4 (6.9) 1 (1.7) 1,828 120 (6.6) 12 (0.7)
2018 1,930 112 (5.8) 13 (0.7) 57 7 (12.3) 1 (1.8) 1,863 104 (5.6) 12 (0.6)
2017 1,906 107 (5.6) 19 (1.0) 59 3 (5.1) 2 (3.4) 1,844 104 (5.6) 17 (0.9)
2016 2,140 130 (6.1) 8 (0.4) 83 7 (8.4) 0 (0.0) 2,051 122 (5.9) 8 (0.4)
2015 2,297 158 (6.9) 13 (0.6) 101 7 (6.9) 3 (3.0) 2,191 150 (6.8) 10 (0.5)
2014 2,274 167 (7.3) 10 (0.4) 94 5 (5.3) 0 (0.0) 2,174 162 (7.5) 10 (0.5)
2013 2,389 142 (5.9) 10 (0.4) 99 9 (9.1) 3 (3.0) 2,276 130 (5.7) 7 (0.3)
2012 2,646 154 (5.8) 13 (0.5) 126 8 (6.3) 0 (0.0) 2,513 146 (5.8) 13 (0.5)
2011 2,832 182 (6.4) 18 (0.6) 136 10 (7.4) 1 (0.7) 2,682 171 (6.4) 17 (0.6)
2010 3,076 179 (5.8) 17 (0.6) 132 13 (9.8) 3 (2.3) 2,921 165 (5.6) 14 (0.5)
2009 3,229 201 (6.2) 13 (0.4) 116 6 (5.2) 1 (0.9) 3,087 192 (6.2) 12 (0.4)
2008 3,853 202 (5.2) 24 (0.6) 171 13 (7.6) 3 (1.8) 3,644 188 (5.2) 21 (0.6)
2007 4,074 181 (4.4) 22 (0.5) 206 14 (6.8) 3 (1.5) 3,846 163 (4.2) 18 (0.5)
2006 4,348 184 (4.2) 20 (0.5) 204 9 (4.4) 1 (0.5) 4,122 172 (4.2) 19 (0.5)
2005 4,662 210 (4.5) 23 (0.5) 240 18 (7.5) 2 (0.8) 4,394 188 (4.3) 20 (0.5)
2004 4,969 229 (4.6) 30 (0.6) 274 15 (5.5) 4 (1.5) 4,678 213 (4.6) 26 (0.6)
2003 5,141 231 (4.5) 26 (0.5) 253 16 (6.3) 2 (0.8) 4,846 213 (4.4) 23 (0.5)
2002 5,438 231 (4.2) 38 (0.7) 304 23 (7.6) 3 (1.0) 5,056 205 (4.1) 35 (0.7)
2001 5,959 271 (4.5) 41 (0.7) 324 28 (8.6) 7 (2.2) 5,566 240 (4.3) 34 (0.6)
2000 6,550 294 (4.5) 42 (0.6) 360 22 (6.1) 2 (0.6) 6,135 269 (4.4) 40 (0.7)
1999 7,475 319 (4.3) 46 (0.6) 382 25 (6.5) 6 (1.6) 7,007 284 (4.1) 39 (0.6)
1998 8,233 408 (5.0) 61 (0.7) 485 38 (7.8) 6 (1.2) 7,691 365 (4.7) 55 (0.7)
1997 9,183 472 (5.1) 89 (1.0) 455 35 (7.7) 12 (2.6) 8,696 435 (5.0) 76 (0.9)
1996 10,241 565 (5.5) 125 (1.2) 558 68 (12.2) 21 (3.8) 9,630 495 (5.1) 104 (1.1)
1995 10,992 637 (5.8) 199 (1.8) 592 77 (13.0) 28 (4.7) 10,332 554 (5.4) 169 (1.6)
1994 11,780 794 (6.7) 274 (2.3) 691 81 (11.7) 35 (5.1) 11,004 706 (6.4) 238 (2.2)
1993 12,530 873 (7.0) 331 (2.6) 668 83 (12.4) 30 (4.5) 11,802 788 (6.7) 301 (2.6)

1Persons born in the United States, certain U.S. territories, or elsewhere to at least one U.S. citizen parent are categorized as U.S.-born. All other persons are categorized as non-U.S.–born.
2Persons with isolates tested with at least isoniazid and rifiampin.
3Resistance to at least isoniazid.
4Resistance to at least isoniazid and rifampin.

Note: Data for all years are updated through July 8, 2022.